Every financial statement,
one clean chart.
Search any US-listed company. Data straight from SEC filings.
DBV Technologies S.A. (DBVT), most recent 12 months reported: revenue $5.02M, net loss $175.99M, free cash flow -$170.61M. Latest balance sheet on file: liquid cash $194.17M. From SEC filings. More on DBV Technologies S.A.: Revenue · Profitability · Cash flow · Debt Others in Biological Products, (No Diagnostic Substances): ZEO SCIENTIFIX, INC · FATE THERAPEUTICS INC · CG Oncology, Inc. · Taysha Gene Therapies, Inc. · Prime Medicine, Inc. · OCUGEN, INC. · CURIS, INC. · DYADIC INTERNATIONAL INC
Filter every US company by the numbers — net cash, margins, ROIC, growth. Looking for one company? The search box above is free.
Follow a company and we'll email you when it files a quarterly or annual report with the SEC. Free follows 3 companies; Pro follows up to 500, and sorts and filters them.